We also found that upregulated genes with low DAB2IP in Luminal A breast tumors were enriched in nonclassical estrogen and ESR1-regulated genes, which may affect responses to endocrine therapies and also drive proliferation (Figure 2E). This evidence concerns the gene ESR1 and breast neoplasm.